A diagnostics test developed by the University of Liverpool for monitoring anti-HIV
drugs in the blood is to be made available across Europe. The test has been
acquired by Delphic Europe - a diagnostics products provider - which will develop
it in conjunction with viral resistance testing for market on the continent.